STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
The Society of Thoracic Surgeons
Study ID
NCT01737528
Status
Recruiting
Apply to this trial

Conditions

  • Aortic Valve Stenosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Transcatheter Aortic Valve Replacement — PROCEDURE
    Minimal invasive implantation of a biological prothesis in Aortic Position

Study Details

The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter aortic valve replacement (TAVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monitor the safety and efficacy of this new procedure for the treatment of aortic stenosis.

Key Dates

Start date
Jun 30, 2012
Status verified
Nov 2021
Primary completion
Jun 30, 2035
Completion
Jun 30, 2035

Study Design

Enrollment
16,000 participants (estimated)

Arms

  • Arm: TAVR Patients
    Will include all patients 18 years or over who undergo Transcatheter Aortic Valve Replacement (TAVR) for severe aortic stenosis. The sample size will include all patients entered into the Registry.

Primary Outcome Measure

Major adverse cardiac and cerebrovascular events [ Time Frame: 30 day ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
American College of CardiologyWashington D.C.District of Columbia20037
Joan Michaels
[email protected]
202-375-6309

Find similar trials in Washington D.C., DC

By research site
American College of Cardiology· Washington D.C., DC

Related Studies